BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
22 results:

  • 1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian cancer.
    Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
    JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. SERPINE2 promotes liver cancer metastasis by inhibiting c-cbl-mediated EGFR ubiquitination and degradation.
    Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
    Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Using a Nomogram to Preoperatively Predict Distant Metastasis of pancreatic Neuroendocrine Tumor in Elderly Patients.
    Li G; Bing YT; Tian ML; Yuan CH; Xiu DR
    Chin Med Sci J; 2021 Sep; 36(3):218-224. PubMed ID: 34666875
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Resected pancreatic cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy.
    Liu C; Cheng H; Jin K; Fan Z; Gong Y; Qian Y; Deng S; Huang Q; Ni Q; Yu X; Luo G
    Cancer Control; 2020; 27(1):1073274820915947. PubMed ID: 32268796
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cbl0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins.
    Albahde MAH; Zhang P; Chen H; Wang W
    Neoplasma; 2020 May; 67(3):547-556. PubMed ID: 32202904
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of Care and Outcomes of Adjuvant Chemoradiation for Node-Positive pancreatic Adenocarcinoma.
    Malakhov N; Lee A; Albert A; Lederman A; Byun J; Safdieh J; Schreiber D
    J Gastrointest Cancer; 2020 Jun; 51(2):506-514. PubMed ID: 31236851
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
    Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
    Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Current status of surgical treatment of gastric gastrointestinal tumors: a national multi-center retrospective study].
    Feng X; Li R; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Sun X; Yu J; Chen Z; Zhao Y; Liu X; Li J; Zhang B; Zhou Y; Huang C; Zhou Z; Li G; Tao K; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1258-1264. PubMed ID: 27928796
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth.
    Pan T; Zhang Y; Zhou N; He X; Chen C; Liang L; Duan X; Lin Y; Wu K; Zhang H
    Oncotarget; 2016 Jul; 7(28):44299-44309. PubMed ID: 27322423
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program.
    Joergensen MT; Gerdes AM; Sorensen J; Schaffalitzky de Muckadell O; Mortensen MB
    Pancreatology; 2016; 16(4):584-92. PubMed ID: 27090585
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells.
    Dong Y; Liang C; Zhang B; Ma J; He X; Chen S; Zhang X; Chen W
    Cancer Lett; 2015 May; 361(1):137-46. PubMed ID: 25737303
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Low expression of the E3 ubiquitin ligase cbl confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.
    Kadera BE; Toste PA; Wu N; Li L; Nguyen AH; Dawson DW; Donahue TR
    Clin Cancer Res; 2015 Jan; 21(1):157-65. PubMed ID: 25348515
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of diabetes mellitus on the outcome of pancreatic cancer.
    Beg MS; Dwivedi AK; Ahmad SA; Ali S; Olowokure O
    PLoS One; 2014; 9(5):e98511. PubMed ID: 24879130
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Four-arm PEG cross-linked hyaluronic acid hydrogels containing PEGylated apoptotic TRAIL protein for treating pancreatic cancer.
    Byeon HJ; Choi SH; Choi JS; Kim I; Shin BS; Lee ES; Park ES; Lee KC; Youn YS
    Acta Biomater; 2014 Jan; 10(1):142-50. PubMed ID: 24021228
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. UVC radiation induces downregulation of EGF receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells.
    Yamauchi T; Adachi S; Yasuda I; Nakashima M; Kawaguchi J; Nishii Y; Yoshioka T; Okano Y; Hirose Y; Kozawa O; Moriwaki H
    Radiat Res; 2011 Nov; 176(5):565-74. PubMed ID: 21692654
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cells.
    Hill KS; Lorinczi M; Elferink LA
    J Exp Ther Oncol; 2010; 8(4):297-312. PubMed ID: 21222362
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer.
    Chang Q; Jorgensen C; Pawson T; Hedley DW
    Br J Cancer; 2008 Oct; 99(7):1074-82. PubMed ID: 18797457
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.